New and Special Drug
-
Tofidence (Tocilizumab) – Immunology | HongKong DengYue Medicine
-
Quinlock Ripretinib – GIST | HongKong DengYue Medicine
-
Orkedia (Evocalcet) | Secondary Hyperparathyroidism | DengYue
-
Tremfya (Guselkumab) | Plaque Psoriasis | DengYue Medicine
-
Entyvio (Vedolizumab) | Ulcerative Colitis | DengYue Medicine
-
Hengmu (Tenofovir Amibufenamide) | CHB | HongKong DengYue
-
Litfulo (Ritlecitinib) | Severe Alopecia Areata | DengYue Medicine
-
Leqvio (Inclisiran) | ASCVD | HongKong DengYue Medicine
-
Praluent (Alirocumab) | ASCVD | HongKong DengYue Medicine
-
Repatha (Evolocumab) | ASCVD | HongKong DengYue Medicine
-
Nemluvio (Nemolizumab-ilto) – Prurigo Nodularis | HongKong DengYue Medicine
-
Livdelzi (Seladelpar) | Primary Biliary Cholangitis | DengYue Med
-
Yorvipath (Palopegteriparatide) | Hypoparathyroidism | DengYue Medicine
-
Voranigo (vorasidenib) – IDH1/IDH2-Mutant Grade 2 Gliomas
-
Sofdra (Sofpironium) | Primary Axillary Hyperhidrosis | DengYue
-
Ohtuvayre (Ensifentrine) – Chronic Obstructive Pulmonary Disease
